Consistent with the mRNA data, the protein levels of GBM CSC marker CD133 and TMZ resistance-associated protein MGMT were obviously much higher in the SP cells compared with the parental and non-SP cells (Fig. 4(C)). This evidence concerns the gene PROM1 and glioblastoma.